NAD+

weak data

Also seen as: Nicotinamide Adenine Dinucleotide, NAD, nicotinamide adenine dinucleotide

The Dose Guy’s verdict

Sep 1, 2026
2 sources

The coenzyme every anti-aging clinic sells by IV, and the case is strongest for older adults chasing vitality, where cellular NAD+ levels have genuinely declined. If you are young and healthy, it is an expensive, uncomfortable afternoon for a result you probably will not feel. The one published oral trial raised NAD+ inside cells, then watched nothing clinical move. Oral precursors like NR or NMN are cheaper, easier, and have at least as much evidence behind them.

Would I take it?Maybe if you're 60+, skip the drip otherwise.

What it is

Nicotinamide adenine dinucleotide, a coenzyme that sits at the center of hundreds of metabolic reactions, the place where cellular energy, DNA repair, and aging-related signaling converge. NAD+ levels decline with age, and the entire anti-aging NAD industry rests on one idea: put it back, restore the function. The delivery splits two ways. The clinic route is a slow IV infusion, typically 2 to 4 hours in a chair, uncomfortable and expensive. The home route is oral precursors, NR or NMN, which your body converts into NAD+. A newer option is direct oral NAD+ in a formulated capsule, which landed its first published trial in 2026.

The mechanism is real, the decline with age is real, and the idea of replenishing it is reasonable. What is missing is proof that replenishing it changes how you feel or function, especially if you are under 60 and already healthy.

What the research shows

One small oral trial and a gap where the IV validation should be:

Five days of oral formulated NAD+ raised whole-blood intracellular NAD by 53% versus placebo in the 50 adults who completed the primary analysis. No secondary clinical, vital-sign, wellbeing, or wearable-derived endpoint survived correction for multiple testing. NAD went up in cells. Nothing else moved.GeroScience 2026 · phase 0/1b · n=60

Intravenous NAD+ is less well characterized than oral precursor use and lacks strong clinical validation. The drip everyone sells has the thinnest published support.Mol Biol Rep 2026 · review

The disconnect: clinics have dripped NAD+ into thousands of people, and the published literature behind that practice is nearly empty.as of Aug 2026

Realistic protocols

The IV drip runs 250 to 500 mg infused slowly, 2 to 4 hours in a chair at a clinic, usually once or twice a month. Infusion speed is the side-effect dial: push it faster and the chest tightness and nausea spike, so clinics slow the drip until you can tolerate it. Most people find the first session the roughest, with later ones easier.

If you want to skip the drip entirely, oral NR or NMN at 300 to 500 mg daily is the simpler play, with comparable evidence for raising blood NAD+ and none of the chair time or cost. The direct oral NAD+ formulation raised intracellular levels in its one published trial, but nothing clinical moved, so whether more NAD+ in cells translates to anything you can feel is still the open question.

IV drip250–500 mgSlow infusion, 2–4 hours. Speed is the side-effect dial.

IV frequency1–2x/monthMonthly is typical. More often is more money, not proven better.

Oral NR/NMN300–500 mg/dayCheaper, easier, comparable blood-level evidence.

TimingMorningThe energy effect, real or perceived, can interfere with sleep.

Side effects

Most of the discomfort is the delivery, not the molecule:

anecdotalChest tightness, nausea, flushing, and anxiety during IV infusion, reported by nearly everyone and dose-rate dependent. Slow the drip and they ease.

anecdotalInsomnia when infused late in the day. Schedule sessions in the morning.

unknownLong-term effects of chronically elevating NAD+ in a young, healthy person are unstudied. The natural decline with age may serve a purpose nobody has characterized.